BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 35402361)

  • 21. Common variable immunodeficiency with granulomatous-lymphocytic interstitial lung disease and preceding neurological involvement: a case-report.
    Cowen JE; Stevenson J; Paravasthu M; Darroch J; Jacob A; Tueger S; Gosney JR; Simons A; Spencer LG; Judge EP
    BMC Pulm Med; 2020 Jul; 20(1):205. PubMed ID: 32736614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulomatous Lymphocytic Interstitial Lung Disease in a Spectrum of Pediatric Primary Immunodeficiencies.
    Szczawinska-Poplonyk A; Jonczyk-Potoczna K; Mikos M; Ossowska L; Langfort R
    Pediatr Dev Pathol; 2021; 24(6):504-512. PubMed ID: 34176349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined immunodeficiency (CVID and CD4 lymphopenia) is associated with a high risk of malignancy among adults with primary immune deficiency.
    Shavit R; Maoz-Segal R; Frizinsky S; Haj-Yahia S; Offengenden I; Machnas-Mayan D; Tunisky Y; Iancovici-Kidon M; Agmon-Levin N
    Clin Exp Immunol; 2021 May; 204(2):251-257. PubMed ID: 33497464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune Monitoring of Patients With Primary Immune Regulation Disorders Unravels Higher Frequencies of Follicular T Cells With Different Profiles That Associate With Alterations in B Cell Subsets.
    Caldirola MS; Martínez MP; Bezrodnik L; Zwirner NW; Gaillard MI
    Front Immunol; 2020; 11():576724. PubMed ID: 33193371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphoproliferative Disease in CVID: a Report of Types and Frequencies from a US Patient Registry.
    Yakaboski E; Fuleihan RL; Sullivan KE; Cunningham-Rundles C; Feuille E
    J Clin Immunol; 2020 Apr; 40(3):524-530. PubMed ID: 32185577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low percentages of regulatory T cells in common variable immunodeficiency (CVID) patients with autoimmune diseases and its association with increased numbers of CD4+CD45RO+ T and CD21
    López-Herrera G; Segura-Méndez NH; O'Farril-Romanillos P; Nuñez-Nuñez ME; Zarate-Hernández MC; Mogica-Martínez D; Yamazaki-Nakashimada MA; Staines-Boone AT; Santos-Argumedo L; Berrón-Ruiz L
    Allergol Immunopathol (Madr); 2019; 47(5):457-466. PubMed ID: 31103252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pediatric common variable immunodeficiency - from genetics to therapy: a review.
    Szczawinska-Poplonyk A; Schwartzmann E; Bukowska-Olech E; Biernat M; Gattner S; Korobacz T; Nowicki F; Wiczuk-Wiczewska M
    Eur J Pediatr; 2022 Apr; 181(4):1371-1383. PubMed ID: 34939152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating Helper T-Cell Subsets and Regulatory T Cells in Patients With Common Variable Immunodeficiency Without Known Monogenic Disease.
    Azizi G; Mirshafiey A; Abolhassani H; Yazdani R; Jafarnezhad-Ansariha F; Shaghaghi M; Mortazavi-Jahromi SS; Noorbakhsh F; Rezaei N; Aghamohammadi A
    J Investig Allergol Clin Immunol; 2018; 28(3):172-181. PubMed ID: 29345621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical manifestations and approach to the management of patients with common variable immunodeficiency and liver disease.
    Daza-Cajigal V; Segura-Guerrero M; López-Cueto M; Robles-Marhuenda Á; Camara C; Gerra-Galán T; Gómez-de-la-Torre R; Avendaño-Monje CL; Sánchez-Ramón S; Bosque-Lopez MJ; Quintero-Duarte A; Bonet-Vidal ML; Pons J
    Front Immunol; 2023; 14():1197361. PubMed ID: 37342345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in
    Klemann C; Camacho-Ordonez N; Yang L; Eskandarian Z; Rojas-Restrepo JL; Frede N; Bulashevska A; Heeg M; Al-Ddafari MS; Premm J; Seidl M; Ammann S; Sherkat R; Radhakrishnan N; Warnatz K; Unger S; Kobbe R; Hüfner A; Leahy TR; Ip W; Burns SO; Fliegauf M; Grimbacher B
    Front Immunol; 2019; 10():297. PubMed ID: 30941118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and immunological features of common variable immunodeficiency in Mexican patients.
    Ramírez-Vargas N; Arablin-Oropeza SE; Mojica-Martínez D; Yamazaki-Nakashimada MA; de la Luz García-Cruz M; Terán-Juárez LM; Cortés-Grimaldo RM; Torres-Lozano C; Madrigal-Beas I; Ortega-Cisneros M; Vargas-Camaño ME; Staines-Boone T; Pietropaolo-Cienfuegos D; Berrón-Ruiz L; Espinosa-Rosales FJ; Guevara-Cruz M; Blancas-Galicia L
    Allergol Immunopathol (Madr); 2014; 42(3):235-40. PubMed ID: 23578780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association Between Cytometric Biomarkers, Clinical Phenotype, and Complications of Common Variable Immunodeficiency.
    Markocsy A; Bobcakova A; Petrovicova O; Kapustova L; Malicherova Jurkova E; Schniederova M; Petriskova J; Cibulka M; Hyblova M; Jesenak M
    Cureus; 2024 Jan; 16(1):e52941. PubMed ID: 38406025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-infectious Complications of Common Variable Immunodeficiency: Updated Clinical Spectrum, Sequelae, and Insights to Pathogenesis.
    Ho HE; Cunningham-Rundles C
    Front Immunol; 2020; 11():149. PubMed ID: 32117289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Common variable immunodeficiency: an update.
    Salzer U; Warnatz K; Peter HH
    Arthritis Res Ther; 2012 Sep; 14(5):223. PubMed ID: 23043756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study.
    Boileau J; Mouillot G; Gérard L; Carmagnat M; Rabian C; Oksenhendler E; Pasquali JL; Korganow AS;
    J Autoimmun; 2011 Feb; 36(1):25-32. PubMed ID: 21075598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune disorders associated with common variable immunodeficiency: prediction, diagnosis, and treatment.
    Yazdanpanah N; Rezaei N
    Expert Rev Clin Immunol; 2022 Dec; 18(12):1265-1283. PubMed ID: 36197300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma protein profiling reflects T
    Hultberg J; Ernerudh J; Larsson M; Nilsdotter-Augustinsson Å; Nyström S
    J Allergy Clin Immunol; 2020 Aug; 146(2):417-428. PubMed ID: 32057767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of the Interleukin-21 Pathway with Interleukin-4 Distinguishes Common Variable Immunodeficiency Patients with More Non-infectious Clinical Complications.
    Desjardins M; Béland M; Dembele M; Lejtenyi D; Drolet JP; Lemire M; Tsoukas C; Ben-Shoshan M; Noya FJD; Alizadehfar R; McCusker CT; Mazer BD
    J Clin Immunol; 2018 Jan; 38(1):45-55. PubMed ID: 29103189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up in common variable immunodeficiency: the pediatric-onset and adult-onset landscape.
    Carrabba M; Salvi M; Baselli LA; Serafino S; Zarantonello M; Trombetta E; Pietrogrande MC; Fabio G; Dellepiane RM
    Front Pediatr; 2023; 11():1125994. PubMed ID: 37435172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in Common Variable Immunodeficiency (CVID): A Multicenter Retrospective Study of Patients From Italian PID Referral Centers.
    Cinetto F; Scarpa R; Carrabba M; Firinu D; Lougaris V; Buso H; Garzi G; Gianese S; Soccodato V; Punziano A; Lagnese G; Tessarin G; Costanzo G; Landini N; Vio S; Bondioni MP; Consonni D; Marasco C; Del Giacco S; Rattazzi M; Vacca A; Plebani A; Fabio G; Spadaro G; Agostini C; Quinti I; Milito C
    Front Immunol; 2021; 12():627423. PubMed ID: 33777011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.